#Hong Kong #Anti-Aging #stem cell #Visionary Holdings

Visionary Holdings Launches Innovative Anti-Aging Solution

Visionary Holdings Inc. (Nasdaq: GV), a multinational enterprise acknowledged for its technological prowess, has officially unveiled a new line of anti-aging products based on stem cell technology at its Asia-Pacific headquarters in Hong Kong. This launch aims at catering predominantly to the Chinese mainland and broader Asian markets, marking a significant expansion into the premium sector of regenerative medicine.

A New Era in Anti-Aging Products

The introduction of the stem cell-based anti-aging line comes as a milestone for Visionary Holdings after its entry into the medical aesthetics domain earlier this year. This new product suite aligns with the Company's global partnership and licensing agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. (
Yike”), which emphasizes innovation in regenerative medicine technology and product commercialization.

The product portfolio includes three core offerings:
1. Comprehensive Regenerative Package: This flagship service, named the Life Rejuvenation Program, combines mesenchymal stem cells, NK cell therapy, and AI-driven diagnostics, tailored specifically for entrepreneurs and high-net-worth individuals.
2. Precision Repair Package: This option integrates specialized stem cell therapies and DFPP blood purification, specifically designed for individuals suffering from degenerative or chronic health conditions.
3. Premium Personalized Program: Aiming at ultra-high-net-worth individuals, this program includes comprehensive genome sequencing, dual-institution medical consultations, and personalized health management tailored to individual needs.

Market-Ready Implementation

The recent product launch underscores a strategic evolution from the Research and Development collaborative efforts with Yike into a concrete market execution phase. Visionary Holdings has assimilated Yike's cutting-edge regenerative technologies to create an extensive range of personalized anti-aging solutions. These services encompass stem cell therapy, NK cell rejuvenation, AI health assessments, and nano-delivery systems, all crucial for optimal cellular rejuvenation.

Initial Market Targets

The new anti-aging products will make their debut across major markets in Hong Kong, Singapore, and mainland China, capitalizing on the high demand for customized health solutions among affluent clients in these regions.

To further bolster commercialization, Visionary Holdings plans to:

• - Establish a joint venture aimed at local production and clinical validation of stem cell products.
• - Develop a cross-border sales network connecting mainland China with Hong Kong and Southeast Asia, while extending reach into North America including Canada, the U.S., and Mexico.
• - Collaborate with leading medical and aesthetic institutions to establish branded clinics focused solely on anti-aging experiences.

Leadership's Vision

Xiyong Hou, CEO of Visionary Holdings, expressed pride in the impactful deployment of the Company’s stem cell anti-aging products, stating, "The official launch signifies a pivotal moment in converting our technological expertise into tangible commercial success. Following our collaboration with Yike, we have transitioned from development to offering market-ready products."

As the regenerative aesthetics market in Asia is rapidly growing, this launch not only opens new revenue avenues for Visionary Holdings but also consolidates its position as a leader in longevity and cellular rejuvenation technologies. The Company anticipates that this innovative product line will act as a key driver of profitability in the future while enhancing its market visibility globally.

About Visionary Holdings Inc.

Visionary Holdings Inc. is a technology-focused multinational company dedicated to pioneering education, AI applications, and advanced healthcare solutions. With its headquarters in Toronto, Canada, it operates through various subsidiaries across North America and Asia, leading advancements in technology and global health initiatives.

About Yike Regenerative Medicine

Based in Jiangsu, Yike Regenerative Medicine is a pioneering enterprise specializing in regenerative medicine and precision anti-aging technologies, committed to quality and compliance with global standards. Their partnerships and innovations have positioned them at the forefront of the regenerative medicine field, establishing the Institute of Aging and Regenerative Medicine in conjunction with Jinan University.

Cautionary Note

This announcement contains forward-looking statements, reflecting the Company’s expectations regarding future outcomes, which are subject to numerous risks and uncertainties. Interested parties are encouraged to review Visionary Holdings’ filings with the U.S. Securities and Exchange Commission for additional insights into these factors and potential implications.